Patrick Mucka is a scientist with a robust educational and research background in biochemistry, pharmacology, and molecular biology. Currently, Patrick serves as a Senior Scientist at Bayer, focusing on novel oncology drug targets. Prior to this role, Patrick completed a PhD at Freie Universität Berlin, where they characterized small molecule inhibitors and published findings in Cell Chemical Biology. In addition to previous research experiences at prominent institutions, Patrick has demonstrated an ability to collaborate effectively in diverse teams and has presented research at international conferences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices